275 related articles for article (PubMed ID: 32035968)
21. The PNPLA3 rs738409 C > G polymorphism is associated with the risk of progression to cirrhosis in NAFLD patients.
Vespasiani-Gentilucci U; Gallo P; Porcari A; Carotti S; Galati G; Piccioni L; De Vincentis A; Dell'Unto C; Vorini F; Morini S; Riva E; Picardi A
Scand J Gastroenterol; 2016 Aug; 51(8):967-73. PubMed ID: 27150500
[TBL] [Abstract][Full Text] [Related]
22. Additive effects of PNPLA3 and TM6SF2 on the histological severity of non-alcoholic fatty liver disease.
Koo BK; Joo SK; Kim D; Bae JM; Park JH; Kim JH; Kim W
J Gastroenterol Hepatol; 2018 Jun; 33(6):1277-1285. PubMed ID: 29193269
[TBL] [Abstract][Full Text] [Related]
23. A multi-ethnic study of a PNPLA3 gene variant and its association with disease severity in non-alcoholic fatty liver disease.
Zain SM; Mohamed R; Mahadeva S; Cheah PL; Rampal S; Basu RC; Mohamed Z
Hum Genet; 2012 Jul; 131(7):1145-52. PubMed ID: 22258181
[TBL] [Abstract][Full Text] [Related]
24. Association of metabolic syndrome and patatin-like phospholipase 3 - rs738409 gene variant in non-alcoholic fatty liver disease among a Chennai-based south Indian population.
Narayanasamy K; Karthick R; Panneerselvam P; Mohan N; Ramachandran A; Prakash R; Rajaram M
J Gene Med; 2020 Apr; 22(4):e3160. PubMed ID: 31945251
[TBL] [Abstract][Full Text] [Related]
25. Relationships between Genetic Variations of PNPLA3, TM6SF2 and Histological Features of Nonalcoholic Fatty Liver Disease in Japan.
Akuta N; Kawamura Y; Arase Y; Suzuki F; Sezaki H; Hosaka T; Kobayashi M; Kobayashi M; Saitoh S; Suzuki Y; Ikeda K; Kumada H
Gut Liver; 2016 May; 10(3):437-45. PubMed ID: 26610348
[TBL] [Abstract][Full Text] [Related]
26. A PNPLA3 Polymorphism Confers Lower Susceptibility to Incident Diabetes Mellitus in Subjects With Nonalcoholic Fatty Liver Disease.
Moon S; Chung GE; Joo SK; Park JH; Chang MS; Yoon JW; Koo BK; Kim W
Clin Gastroenterol Hepatol; 2022 Mar; 20(3):682-691.e8. PubMed ID: 33905771
[TBL] [Abstract][Full Text] [Related]
27. Low skeletal muscle mass is associated with more severe histological features of non-alcoholic fatty liver disease in male.
Pan XY; Liu WY; Zhu PW; Li G; Tang LJ; Gao F; Huang OY; Yuan HY; Targher G; Byrne CD; Wang XD; Zheng MH
Hepatol Int; 2022 Oct; 16(5):1085-1093. PubMed ID: 35829867
[TBL] [Abstract][Full Text] [Related]
28. Low hepatic copper content and PNPLA3 polymorphism in non-alcoholic fatty liver disease in patients without metabolic syndrome.
Stättermayer AF; Traussnigg S; Aigner E; Kienbacher C; Huber-Schönauer U; Steindl-Munda P; Stadlmayr A; Wrba F; Trauner M; Datz C; Ferenci P
J Trace Elem Med Biol; 2017 Jan; 39():100-107. PubMed ID: 27908400
[TBL] [Abstract][Full Text] [Related]
29. APOC3 rs2070666 Is Associated with the Hepatic Steatosis Independently of PNPLA3 rs738409 in Chinese Han Patients with Nonalcoholic Fatty Liver Diseases.
Zhang RN; Zheng RD; Mi YQ; Zhou D; Shen F; Chen GY; Zhu CY; Pan Q; Fan JG
Dig Dis Sci; 2016 Aug; 61(8):2284-2293. PubMed ID: 27059980
[TBL] [Abstract][Full Text] [Related]
30. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.
Fracanzani AL; Petta S; Lombardi R; Pisano G; Russello M; Consonni D; Di Marco V; Cammà C; Mensi L; Dongiovanni P; Valenti L; Craxì A; Fargion S
Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682
[TBL] [Abstract][Full Text] [Related]
31. Interactions of allelic variance of PNPLA3 with nongenetic factors in predicting nonalcoholic steatohepatitis and nonhepatic complications of severe obesity.
Guichelaar MM; Gawrieh S; Olivier M; Viker K; Krishnan A; Sanderson S; Malinchoc M; Watt KD; Swain JM; Sarr M; Charlton MR
Obesity (Silver Spring); 2013 Sep; 21(9):1935-41. PubMed ID: 23418085
[TBL] [Abstract][Full Text] [Related]
32. More Evidence for the Genetic Susceptibility of Mexican Population to Nonalcoholic Fatty Liver Disease through PNPLA3.
Chinchilla-López P; Ramírez-Pérez O; Cruz-Ramón V; Canizales-Quinteros S; Domínguez-López A; Ponciano-Rodríguez G; Sánchez-Muñoz F; Méndez-Sánchez N
Ann Hepatol; 2018 Mar; 17(2):250-255. PubMed ID: 29469042
[TBL] [Abstract][Full Text] [Related]
33. I148M patatin-like phospholipase domain-containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease.
Valenti L; Alisi A; Galmozzi E; Bartuli A; Del Menico B; Alterio A; Dongiovanni P; Fargion S; Nobili V
Hepatology; 2010 Oct; 52(4):1274-80. PubMed ID: 20648474
[TBL] [Abstract][Full Text] [Related]
34. Impact of the Association Between PNPLA3 Genetic Variation and Dietary Intake on the Risk of Significant Fibrosis in Patients With NAFLD.
Vilar-Gomez E; Pirola CJ; Sookoian S; Wilson LA; Belt P; Liang T; Liu W; Chalasani N
Am J Gastroenterol; 2021 May; 116(5):994-1006. PubMed ID: 33306506
[TBL] [Abstract][Full Text] [Related]
35. The association of nonalcoholic fatty liver disease with genetic polymorphisms: a multicenter study.
Uygun A; Ozturk K; Demirci H; Oztuna A; Eren F; Kozan S; Yilmaz Y; Kurt O; Turker T; Vatansever S; Alper E; Unsal B
Eur J Gastroenterol Hepatol; 2017 Apr; 29(4):441-447. PubMed ID: 28253210
[TBL] [Abstract][Full Text] [Related]
36. [Polymorphism rs738409 in PNPLA3 is associated with inherited susceptibility to non-alcoholic fatty liver disease].
Xu J; Xin YN; Lü WH; Lin ZH; Zhang DD; Zhang M; Dong QJ; Jiang XJ; Xuan SY
Zhonghua Gan Zang Bing Za Zhi; 2013 Aug; 21(8):619-23. PubMed ID: 24119744
[TBL] [Abstract][Full Text] [Related]
37. Relationship Between PNPLA3 rs738409 Polymorphism and Decreased Kidney Function in Children With NAFLD.
Targher G; Mantovani A; Alisi A; Mosca A; Panera N; Byrne CD; Nobili V
Hepatology; 2019 Jul; 70(1):142-153. PubMed ID: 30912854
[TBL] [Abstract][Full Text] [Related]
38. Association Between PNPLA3 rs738409 C>G Variant and Liver-Related Outcomes in Patients With Nonalcoholic Fatty Liver Disease.
Grimaudo S; Pipitone RM; Pennisi G; Celsa C; Cammà C; Di Marco V; Barcellona MR; Boemi R; Enea M; Giannetti A; Spatola F; Marchesini G; Craxì A; Petta S
Clin Gastroenterol Hepatol; 2020 Apr; 18(4):935-944.e3. PubMed ID: 31419571
[TBL] [Abstract][Full Text] [Related]
39. The role of mitochondrial genomics in patients with non-alcoholic steatohepatitis (NASH).
Mehta R; Jeiran K; Koenig AB; Otgonsuren M; Goodman Z; Baranova A; Younossi Z
BMC Med Genet; 2016 Sep; 17(1):63. PubMed ID: 27596100
[TBL] [Abstract][Full Text] [Related]
40. Association between patatin-like phospholipase domain containing 3 gene (PNPLA3) polymorphisms and nonalcoholic fatty liver disease: a HuGE review and meta-analysis.
Xu R; Tao A; Zhang S; Deng Y; Chen G
Sci Rep; 2015 Mar; 5():9284. PubMed ID: 25791171
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
